Analgesic effects of botulinum toxin A: A randomized, placebo-controlled clinical trial

Developmental Medicine and Child Neurology

Volumn 42, Issue 2, 2000, Pages 116-121

  Barwood, Shane ^a   Baillieu, Charles ^a   Boyd, Roslyn ^a   Brereton, Kate ^a   Low, Janette ^a   Nattrass, Gary ^a   Graham, H Kerr ^a  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; BOTULINUM TOXIN A; CODEINE; DIAZEPAM; METOCLOPRAMIDE; MORPHINE; OPIATE; PARACETAMOL;

ARTICLE; CEREBRAL PALSY; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DENERVATION; DOUBLE BLIND PROCEDURE; DRUG WITHDRAWAL; HUMAN; KIDNEY FAILURE; MUSCLE SPASM; NAUSEA; POSTOPERATIVE PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPASTICITY; VOMITING;

BOTULINUM TOXIN TYPE A; CEREBRAL PALSY; CHILD; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; FEMALE; HIP DISLOCATION; HUMANS; MALE; MUSCLE CONTRACTION; MUSCLE, SKELETAL; NEUROMUSCULAR AGENTS; PAIN, POSTOPERATIVE; TREATMENT OUTCOME;

EID: 0033965674     PISSN: 00121622     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-8749.2000.tb00056.x     Document Type: Article

References (37)

1. Banks HH, Green WT. (1960) Adductor myotomy and obturator neurectomy for the correction of adduction contracture of the hip in cerebral palsy. Journal of Bone and Joint Surgery 42A: 111-26.
2. Bleck EE. (1987) Orthopaedic Management in Cerebral Palsy. Philadelphia: Lippincott.
3. _ (1990) Current concepts review. Management of the lower extremities in children who have cerebral palsy. Journal of Bone and Joint Surgery 72: 140-4.
4. Bohannon RW, Smith MB. (1986) Interrater reliability of a modified Ashworth scale of muscle spasticity. Physical Therapy 67: 206-7.
5. Boyd RN, Graham HK. (1997) Botulinum toxin A in the management of children with cerebral palsy: indications and outcomes. European Journal of Neurology 4: (Suppl.) 15-22.
6. _ Barwood SA, Ballieu C, Graham HK. (1998) Validity of a clinical measure of spasticity in children with cerebral palsy in a double blinded randomised controlled clinical trial. Developmental Medicine & Child Neurology 40: (Suppl.) 7. (Abstract.)
7. Brin MF. (1997) Botulinum toxin: chemistry, pharmacology, toxicity, and immunology. Muscle and Nerve 6: (Suppl.) 146-68.
8. Cooperman DR, Bartucci E, Dietrick E, Millar EA. (1986) Hip dislocation in spastic cerebral palsy: long term consequences. Journal of Pediatric Orthopedics 7: 268-76.
9. Cornell MS. (1995) The hip in cerebral palsy. Developmental Medicine & Child Neurology 37: 3-18.
10. _ Hatrick CN, Boyd R, Baird G, Spencer JD. (1997) The hip in children with cerebral palsy: predicting the outcome of soft tissue surgery. Clinical Orthopaedics and Related Research. 340: 165-71.
11. Cosgrove AP, Corry IS, Graham HK. (1994) Botulinum toxin in the management of the lower limb in cerebral palsy. Developmental Medicine & Child Neurology 36: 386-96.
12. Cousins MJ. (1989) Acute pain and the injury response: immediate and prolonged effects. Regional Anaesthesia 14: 162-79.
13. _ (1994) Acute and postoperative pain. In: Wall PD, Melzack R, editors. Textbook of Pain. Edinburgh: Churchill Livingstone. p 357-86.
14. Cullen MI, Staren ED, el Ganzouri A, Logas WG, Ivankovitch AD, Economov SG. (1985) Continuous epidural infusion for analgesia after major abdominal operations: a randomized, prospective double blind study. Surgery 98: 718-26.
15. De Paiva A, Meunier FA, Molgo J, Aoki R, Dolly RO. (1999) Functional repair of motor endplates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals. Proceedings National Academy Science USA 96: 3200-5.
16. Dolly JO, Black J, Williams RS, Melling J. (1984) Acceptors for botulinum neurotoxin reside on motor nerve terminals and mediate its internalization. Nature 307: 457-60.
17. _ Ashton AC, McInnes C, Wadsworth JDF, Poulain B, Tqauc L, Shone CC. (1990) Clues to the multiplastic inhibitory action of botulinum neurotoxins on release of transmitters. Journal of Physiology (Paris) 84: 237-46.
18. Duchen LW, Strich S. (1968) The effects of botulinum toxin on the patterns of innervation of skeletal muscle in the mouse. Quarterly Journal of Experimental Physiology 236: 733-42.
19. Duncan B. (1947) The Development of Inhalational Anaesthetics. London: Geoffrey Cumberlege.
20. Graham HK. (1997) The orthopaedic management of cerebral palsy. In: Broughton NS, editor. A Textbook of Paediatric Orthopaedics. London: WB Saunders. p 101-14.
21. Houkom JA, Roach JW, Wenger DR, Speck G, Herring JA, Norris EN. (1986) Treatment of acquired hip subluxation in cerebral palsy. Journal of Pediatric Orthopedics 6: 285-90.
22. Koman LA, Mooney JF III, Smith BP, Goodman A, Mulvaney T. (1993) Management of cerebral palsy with botulinum-A toxin: preliminary investigation. Journal of Pediatric Orthopedics 13: 489-95.
23. _ Smith BP, Goodman A, Mulvaney T. (1994) Management of spasticity in cerebral palsy with botulinum-A toxin: report of a preliminary, randomized, double-blind trial. Journal of Pediatric Orthopedics 14: 299-303.
24. Lonstein J, Bleck K. (1986) Hip dislocation and subluxation in cerebral palsy. Journal of Pediatric Orthopedics 6: 521-6.
25. McGrath PJ, Unruh AM (1994) Measurement and assessment of paediatric pain. In: Wall PD, Melzack R, editors. Textbook of Pain. Edinburgh: Churchill Livingston. p 306.
26. Miller F, Dabney KW, Rang M. (1995) Complications in cerebral palsy. In: Epps CH Jr, Bowen JR, editors. Complications in Pediatric Surgery. Philadelphia: JB Lippincott. p 477-544.
27. Palisano R, Rosenbaum P, Walter S, Russell D, Wood E, Galuppi B. (1997) Development and reliability of a system to classify gross motor function in children with cerebral palsy. Developmental Medicine & Child Neurology 39: 214-23.
28. Rang M. (1990) Cerebral palsy. In: Morrissey R, editor. Pediatric Orthopaedics, 3rd edn. Vol 1. Philadelphia: JB Lippincott. p 465-506.
29. Reimers J. (1980) The stability of the hip in children. A radiologic study of the results of muscle surgery in cerebral palsy. Acta Orthopaedica Scandinavica. 184: (Suppl.) 12-17.
30. Scrutton D, Baird G. (1997) Surveillance measures of the hips of children with bilateral cerebral palsy. Archives of Disease in Childhood 76: 381-4.
31. Shaari CM, George E, Wu BL, Biller HF, Sanders I. (1991) Quantifying the spread of botulinum toxin through muscle fascia. Laryngoscope 101: 960-4.
32. Sharrard WJW, Allens JMH, Heaney SH, Prendiville GRG. (1975) Surgical prophylaxis of subluxation and dislocation of the hip in cerebral palsy. Journal of Bone and Joint Surgery 57B: 160-6.
33. Solomon GD. (1994) Analgesic medications. In: Tollison A, Satterwaithe J, Tollison R, editors. Handbook of Pain Management, 2nd edn. Baltimore, MD: Williams and Wilkins. p 155-64.
34. Tardieu G, Centaur S, Delaru R. (1954) À la recherche Dune technique de mesure de la spasticité. Imprimé avec le periodique. Revue Neurologique 91: 143-4.
35. Wall SA, Chait LA, Temlett JA, Perkins B, Hillen G, Becker P (1993) Botulinum A chemodenervation: a new modality in cerebral palsied hands. British Journal of Plastic Surgery 46: 703-6.
36. Wheeler M, Weinstein S. (1984) Adductor tenotomy-obturator neurectomy. Journal of Pediatric Orthopedics 4: 48-52.
37. Yates DAH, Smith MA. (1994) Orthopaedic pain after trauma. In: Wall PD, Melzack R, editors. Textbook of Pain. Edinburgh: Churchill Livingstone. p 409.